Two Sigma Securities’s Intelligent Bio Solutions INBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,540
Closed -$21.6K 1807
2024
Q4
$21.6K Buy
+1,540
New +$23.5K ﹤0.01% 1303
2024
Q1
Sell
-245
Closed -$9.95K 3259
2023
Q4
$9.95K Buy
+245
New +$9.63K ﹤0.01% 2814
2022
Q3
Sell
-5
Closed -$7K 2835
2022
Q2
$7K Sell
5
-10
-67% -$16.9K ﹤0.01% 2088
2022
Q1
$28K Buy
15
+8
+114% +$18.4K ﹤0.01% 1936
2021
Q4
$24K Buy
+7
New +$32.1K ﹤0.01% 1384

Other funds holding INBS

Two Sigma Securities's INBS Position: Q1 2025 in Review

Two Sigma Securities sold out of Intelligent Bio Solutions (INBS) in Q1 2025, closing a stake of 1,540 shares — an estimated $21.6K sold.

Two Sigma Securities first reported a position in INBS in Q4 2021 and held it in 5 quarters. The position peaked at $28K in Q1 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q1 2025.

  • Two Sigma Securities reported no remaining Intelligent Bio Solutions position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,540 Intelligent Bio Solutions shares in Q1 2025, an estimated $21.6K.
  • Two Sigma Securities first reported a position in Intelligent Bio Solutions in Q4 2021 and held it in 5 quarters.
  • Two Sigma Securities's Intelligent Bio Solutions position peaked at $28K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.